# Peking University People's Hospital

Organization · id `cardio:org-peking-university-people-s-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 035adwg89](<https://ror.org/035adwg89>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 7 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 035adwg89 by an exact name.

## The registry's words

- Sponsor name: Peking University People's Hospital
- Sponsor class: OTHER
- ROR name: Peking University People's Hospital

## Connected pages

- Sponsors: Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage (`cardio:ct-nct02367248`)
- Sponsors: Randomised Evaluation of Sodium Dialysate Levels on Vascular Events (`cardio:ct-nct02823821`)
- Sponsors: Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes (`cardio:ct-nct03194945`)
- Sponsors: Safety and Efficacy of Statins for Chinese Patients With Dyslipidemia (`cardio:ct-nct03418974`)
- Sponsors: Asian Diabetes Outcomes Prevention Trial (`cardio:ct-nct04286399`)
- Sponsors: The Effect of Glimepiride Compared With Sitagliptin as an add-on Therapy to Metformin in Severe Insulin Deficiency Diabetes (`cardio:ct-nct05386186`)
- Sponsors: The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes (`cardio:ct-nct06408532`)

## Provenance

Content hash: 0a3776004b6422c0e0b323b46051218a7e668698ae0f68a3fa1e54fddfa7bee2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
